Ultragenyx Pharmaceutical Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ultragenyx Pharmaceutical Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Ultragenyx Pharmaceutical Inc. Operating Margin for the quarter ending September 30, 2024 was -102 %, a 29.1% increase year-over-year.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2023 was -131 %, a 26.6% increase from 2022.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2022 was -179 %, a 64.4% decline from 2021.
  • Ultragenyx Pharmaceutical Inc. annual Operating Margin for 2021 was -109 %, a 10.8% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -131 +47.5 +26.6% Jan 1, 2023 Dec 31, 2023
2022 -179 -70 -64.4% Jan 1, 2022 Dec 31, 2022
2021 -109 +13.2 +10.8% Jan 1, 2021 Dec 31, 2021
2020 -122 +287 +70.2% Jan 1, 2020 Dec 31, 2020
2019 -409 +312 +43.3% Jan 1, 2019 Dec 31, 2019
2018 -721 +11.9K +94.3% Jan 1, 2018 Dec 31, 2018
2017 -12.6K +174K +93.2% Jan 1, 2017 Dec 31, 2017
2016 -186K Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.